C07K 14/70514
Cd4
Official title: {cd4}
C07K14/70514 (Cd4) appears on 373 US grants and 446 published applications in this corpus.
Search patents in C07K- Granted patents
- 373
- Published applications
- 446
- Assignees
- 286
- Inventors
- 942
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 2 | 0 |
| 1992 | 10 | 0 |
| 1993 | 8 | 0 |
| 1994 | 6 | 0 |
| 1995 | 9 | 0 |
| 1996 | 9 | 0 |
| 1997 | 15 | 0 |
| 1998 | 29 | 0 |
| 1999 | 18 | 0 |
| 2000 | 20 | 0 |
| 2001 | 17 | 1 |
| 2002 | 14 | 15 |
| 2003 | 7 | 21 |
| 2004 | 7 | 14 |
| 2005 | 3 | 10 |
| 2006 | 5 | 6 |
| 2007 | 6 | 4 |
| 2008 | 10 | 8 |
| 2009 | 3 | 10 |
| 2010 | 4 | 5 |
| 2011 | 2 | 11 |
| 2012 | 9 | 11 |
| 2013 | 7 | 6 |
| 2014 | 6 | 8 |
| 2015 | 6 | 6 |
| 2016 | 4 | 12 |
| 2017 | 4 | 15 |
| 2018 | 8 | 19 |
| 2019 | 10 | 17 |
| 2020 | 15 | 44 |
| 2021 | 15 | 34 |
| 2022 | 19 | 39 |
| 2023 | 12 | 35 |
| 2024 | 14 | 37 |
| 2025 | 23 | 31 |
| 2026 | 17 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Dual CAR expressing T cells individually linked to CD28 and 4-1BB6 Oct 2026US 12,753,218 B2The Trustees of the University of Pennsylvania
- Chimeric antigen receptor for treatment of cancer29 Sep 2026US 12,747,278 B2Industry-Academic Cooperation Foundation, Yonsei University
- Methods and compositions for engineering CD4-deficient CAR T cells and anti-CD4 CAR T cells and uses thereof11 Aug 2026US 12,703,735 B2Seattle Children's Hospital
- Armed dual CAR-T compositions and methods for cancer immunotherapy2 Jun 2026US 12,643,933 B2Simcere Innovation, Inc.
- Modified NK-92 cells, and therapeutic and diagnostic uses thereof21 Apr 2026US 12,606,608 B2Universitatsmedizin Der Johannes Gutenberg-Univeristat Mainz
- Il-13/il-4 superkines: immune cell targeting constructs and methods of use thereof1 Oct 2026US 2026/0297151 A1Medicenna Therapeutics Inc.
- Coreceptor chimeric antigen receptor24 Sep 2026US 2026/0284111 A1
- Anti-cldn18.2 antibodies and diagnostic uses thereof24 Sep 2026US 2026/0284112 A1Antengene Biologics Limited
- Media and methods for differentiating t cells from hematopoietic stem cells17 Sep 2026US 2026/0272984 A1The Regents of the University of California
- Interleukin-18 pretreatment as a cryoprotectant for lymphocytes10 Sep 2026US 2026/0265324 A1The Trustees of the University of Pennsylvania
Most cited
By later US patents
- Method for making heteromultimeric polypeptides932US 5,731,168 AGenentech, Inc. · 1998
- Hybrid immunoglobulins817US 5,116,964 AGenentech, Inc. · 1992
- Recombinant production of immunoglobulin-like domains in prokaryotic cells477US 6,165,745 ABoard of Regents, The University of Texas System · 2000
- Chimeric chains for receptor-associated signal transduction pathways381US 5,359,046 ACell Genesys, Inc. · 1994
- Knobs and holes heteromeric polypeptides342US 7,695,936 B2Genentech, Inc. · 2010